Megestrol acetate to prevent chemo nausea and vomiting
Part of Cancer clinical trials.
This study tests whether megestrol acetate (a hormone-like drug) can help prevent nausea and vomiting caused by strong chemotherapy drugs. It is designed for people with lung cancer who are about to start chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed diagnosis of lung cancer.
- Your doctor expects you to live at least 3 more months.
- If you could become pregnant, you must have a negative pregnancy test and not be breastfeeding.
- You cannot be having radiation therapy within 7 days before or during the first 8 days of treatment.
- You must not have used steroid or sedating antihistamine medications in the last week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking megestrol acetate (a medicine used to stimulate appetite and help gain weight) can reduce weight loss caused by chemotherapy in people with locally advanced colorectal cancer. It may help you maintain strength and energy during treatment.
This study tests whether a medication called megestrol acetate can help reduce severe tiredness and fatigue in people with advanced breast cancer who are receiving a targeted therapy called T-DXd (trastuzumab deruxtecan). Fatigue is a common side effect that can really impact quality of life.
This study tests a new form of the drug megestrol (a medicine that helps with nausea and vomiting) for people receiving their first chemotherapy. It aims to see if it works better than the standard care to prevent the nausea and vomiting that often happens after chemo.
This study tests whether a special form of megestrol acetate (a medicine used to help with weight and appetite) can improve outcomes when given alongside standard chemotherapy and radiation for people with stage III non-small cell lung cancer. It is for patients who are not overweight and who are not already using other appetite-boosting medications.
This trial tests a drug called megestrol acetate to help people with advanced lung cancer who are losing weight or have poor appetite. It aims to improve nutrition and quality of life.
This study tests a new form of megestrol (a medicine that can boost appetite and energy) for people with advanced stomach or colorectal cancer who also have fatigue and poor appetite. It is given as a first treatment, meaning you haven't had chemotherapy yet for your advanced cancer.
Hear when a new Efficacy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.